About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Levomethadone
- Procedure number
- PSUSA/00001855/201905
- Regulatory outcome
- Variation
Documents
Levomethadone: List of nationally authorised medicinal products - PSUSA/00001855/201905
English (EN) (339.96 KB - PDF)
Levomethadone: CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00001855/201905
English (EN) (173.35 KB - PDF)
български (BG) (211.15 KB - PDF)
español (ES) (127.22 KB - PDF)
čeština (CS) (174.86 KB - PDF)
dansk (DA) (149.81 KB - PDF)
Deutsch (DE) (213.2 KB - PDF)
eesti keel (ET) (80.37 KB - PDF)
ελληνικά (EL) (196.04 KB - PDF)
français (FR) (157.53 KB - PDF)
hrvatski (HR) (146.38 KB - PDF)
italiano (IT) (180.89 KB - PDF)
latviešu valoda (LV) (174.59 KB - PDF)
lietuvių kalba (LT) (139.14 KB - PDF)
magyar (HU) (70.5 KB - PDF)
Malti (MT) (216.99 KB - PDF)
Nederlands (NL) (201.83 KB - PDF)
norsk (NO) (111.58 KB - PDF)
polski (PL) (171.04 KB - PDF)
português (PT) (187.54 KB - PDF)
română (RO) (299.18 KB - PDF)
slovenčina (SK) (211.76 KB - PDF)
slovenščina (SL) (119.71 KB - PDF)
Suomi (FI) (122.48 KB - PDF)
svenska (SV) (206.23 KB - PDF)